Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of personalized medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Apr 11, 2022

Eric Adams is the CEO and President of InMed Pharmaceuticals, exploring the benefits of rare cannabinoids from the cannabis plant. We have these naturally occurring cannabinoids in our body and a number of receptors throughout our body that respond to this class of compounds. Because these rare cannabinoids exist in low...


Apr 11, 2022

Eric Adams is the CEO and President of InMed Pharmaceuticals, exploring the benefits of rare cannabinoids from the cannabis plant. We have these naturally occurring cannabinoids in our body and a number of receptors throughout our body that respond to this class of compounds. Because these rare cannabinoids exist in low...


Oct 25, 2021

Dr. Daniel Schneeberger is the CEO of Anebulo Pharmaceuticals and is determined to find an antidote to acute cannabinoid intoxication, a growing problem for people of all ages as well as emergency rooms around the country.

Daniel says, "THC acts mostly in the brain, it crosses the blood-brain barrier and binds to the...


Oct 25, 2021

Dr. Daniel Schneeberger is the CEO of Anebulo Pharmaceuticals and is determined to find an antidote to acute cannabinoid intoxication, a growing problem for people of all ages as well as emergency rooms around the country.

Daniel says, "THC acts mostly in the brain, it crosses the blood-brain barrier and binds to the...


Jul 28, 2021

Dr. Pier Vincenzo Piazza is Co-Founder and CEO of Aelis Farma, a biotechnology company targeting disorders induced by external cannabinoids, the chemical compounds contained in cannabis.  These cannabis-related disorders include addiction, cannabinoid hyperemesis syndrome, and psychosis and are related to how the CB1...